-
First Entry
Apr 15, 06 Patent ExpirationThis is a sample entry. You can delete it from your Control Panel.
Also in this section:
Subscribe to the "News" RSS Feed 
TOP ۞
- Lifestyle switching - Bacillus cereus…
The bacterium B. cereus had so far been considered to…
- One in four hepatitis C…
Nearly one in four patients with chronic hepatitis C (HCV)…
- FDA strengthens warning label for…
The U.S. food and Drug Administration said it was strengthening…
- New target may increase odds…
Researchers from the Johns Hopkins Bloomberg School of Public Health…
- Study shows first signs that…
According to a new study, women experiencing difficulty with time…
- Anti-stroke drug effective treatment for…
An existing anti-stroke drug is an effective treatment for middle-ear…
- Dasabuvir in hepatitis C: Indication…
The drug dasabuvir (trade name Exviera) has been available since…
- U.S. FDA approves Glaxo, Theravance’s…
The U.S. Food and Drug Administration on Thursday approved the…
- Study tallies huge cost of…
A new study finds that effective new hepatitis C drugs…
- Drug regulations tied to fewer…
Well intentioned, but costly and potentially problematic. That’s how researchers…
